Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06562647 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Apr 2025 to Dec 2026
    • Study sites: 1 to 2
    • Study completion date: Apr 2025 to Dec 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Single-arm, dose-increasing setting study of CAR macrophages in Mesothelin overexpressing solid tumors.
Trial Details
NCT Number NCT06562647
Lead Sponsor Cell Origin Biotech (Hangzhou) Co., Ltd.
Conditions
(from sponsor)		 Treatment Related Cancer, Ovarian Cancer
Related terms Neoplasms, Second Primary, Ovarian Neoplasms
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov